肥胖
脂质代谢
益生菌
微生物群
脂肪肝
医学
2型糖尿病
代谢综合征
氧化应激
发病机制
碳水化合物代谢
疾病
生物信息学
生物
糖尿病
内科学
内分泌学
细菌
遗传学
作者
Chao Tang,Liangyu Kong,Mengyuan Shan,Zhaoxin Lu,Yingjian Lu
标识
DOI:10.1016/j.foodres.2021.110490
摘要
Diet-induced obesity is one of the major public health concerns all over the world, and obesity also contributes to the development of other chronic diseases such as non-alcoholic fatty acid liver disease, type 2 diabetes mellitus and cardiovascular diseases. Evidence shows that the pathogenesis of obesity and obesity-associated chronic diseases are closely related to dysregulation of lipid metabolism, glucose metabolism and cholesterol metabolism, and oxidative stress, endoplasmic reticulum stress, abnormal gut microbiome and chronic low-grade inflammation. Recently, in view of potential effects on lipid metabolism, glucose metabolism, cholesterol metabolism and intestinal microbiome, as well as anti-oxidative and anti-inflammatory activities, natural probiotics, including live and dead probiotics, and probiotic components and metabolites, have attracted increasing attention and are considered as novel strategies for preventing and ameliorating obesity and obesity-related chronic diseases. Specifically, this review is presented on the anti-obesity effects of probiotics and underlying molecular mechanisms, which will provide a theoretical basis of anti-obesity probiotics for the development of functional foods.
科研通智能强力驱动
Strongly Powered by AbleSci AI